Bayesian Capital Management LP Purchases Shares of 15,700 Herbalife LTD. (HLF)
Bayesian Capital Management LP purchased a new stake in Herbalife LTD. (NYSE:HLF) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 15,700 shares of the company’s stock, valued at approximately $1,120,000.
Several other institutional investors also recently added to or reduced their stakes in HLF. Acadian Asset Management LLC purchased a new stake in shares of Herbalife LTD. in the 2nd quarter valued at approximately $106,000. MAVEN SECURITIES Ltd purchased a new stake in shares of Herbalife LTD. in the 1st quarter valued at approximately $146,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Herbalife LTD. by 11.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,523 shares of the company’s stock valued at $180,000 after acquiring an additional 268 shares during the period. BlueCrest Capital Management Ltd purchased a new stake in shares of Herbalife LTD. in the 1st quarter valued at approximately $201,000. Finally, Allen Investment Management LLC purchased a new stake in shares of Herbalife LTD. in the 2nd quarter valued at approximately $213,000.
A number of research firms have recently issued reports on HLF. BidaskClub downgraded shares of Herbalife LTD. from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Pivotal Research restated a “buy” rating and issued a $120.00 price objective on shares of Herbalife LTD. in a report on Thursday, August 31st. Zacks Investment Research cut shares of Herbalife LTD. from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 4th. ValuEngine upgraded shares of Herbalife LTD. from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Finally, Tigress Financial restated a “buy” rating on shares of Herbalife LTD. in a report on Wednesday, August 9th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $83.00.
Herbalife LTD. (NYSE:HLF) traded up 0.03% on Thursday, reaching $67.72. 18,148 shares of the company’s stock traded hands. Herbalife LTD. has a 52 week low of $47.62 and a 52 week high of $74.49. The firm has a market capitalization of $6.11 billion, a P/E ratio of 14.24 and a beta of 1.22. The stock has a 50-day moving average of $67.19 and a 200 day moving average of $66.15.
Herbalife LTD. (NYSE:HLF) last issued its quarterly earnings data on Tuesday, August 1st. The company reported $1.51 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.10 by $0.41. Herbalife LTD. had a net margin of 9.28% and a return on equity of 216.82%. The company had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.14 billion. During the same quarter last year, the company earned $1.29 earnings per share. Herbalife LTD.’s revenue for the quarter was down 4.6% on a year-over-year basis. On average, equities analysts expect that Herbalife LTD. will post $4.71 EPS for the current fiscal year.
About Herbalife LTD.
Herbalife Ltd. is a global nutrition company. The Company develops and sells weight management, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, as well as personal care products. Its operating segments are based on geographical operations in six regions: North America; Mexico; South and Central America; Europe, the Middle East, and Africa (EMEA); Asia Pacific, and China.
Want to see what other hedge funds are holding HLF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Herbalife LTD. (NYSE:HLF).
Receive News & Stock Ratings for Herbalife LTD. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife LTD. and related stocks with our FREE daily email newsletter.